Robust in vivo growth of HCmel12 Jak1-KO melanoma cells required antibody-mediated depletion of natural killer (NK) cells before tumour inoculation, in line with the known ability of NK cells to directly recognize and kill MHC-I-deficient cells by cytolysis. The gene discussed is JAK1; the disease is melanoma.